Adding Anti-VEGF to Docetaxel Didn't Improve OS in Bladder Cancer

(MedPage Today) -- Study Authors: Daniel P. Petrylak, Ronald de Wit, et al.; Yair Lotan, Xiaosong MengTarget Audience and Goal Statement: Oncologists, urologists, primary care physicians, internists, family medicine specialistsThe goal of this...